News Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Real-time Estimate Cboe Europe Other stock markets 05:59:58 2024-04-23 am EDT			5-day change	1st Jan Change
883.5 ^DKK	+0.94%		+1.80%	+26.50%

Apr. 22	Health Care Climbs on Earnings Hopes -- Health Care Roundup	DJ
Apr. 22	Eli Lilly to acquire manufacturing facility from Nexus Pharma	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Health Care Climbs on Earnings Hopes -- Health Care Roundup	Apr. 22	DJ
Eli Lilly to acquire manufacturing facility from Nexus Pharma	Apr. 22	RE
Novo Nordisk A/S - share repurchase programme	Apr. 22	GL
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut	Apr. 21	AQ
India's Biocon developing its own version of Wegovy, clinical trial likely next year	Apr. 18	RE
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	Apr. 15	GL
Novo Nordisk A/S - share repurchase programme	Apr. 15	GL
More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm	Apr. 15	RE
Biophytis: patent application filed in the field of obesity	Apr. 15	CF
Health Care Falls as Risk Aversion Weighs on Obesity Drug Makers -- Health Care Roundup	Apr. 12	DJ
European Equities Close Mixed in Friday Trading; German Inflation Slows, UK GDP Rises	Apr. 12	MT
Weight-Loss Drugs Like Wegovy Don't Cause Suicidal Thoughts, EU Says	Apr. 12	DJ
Sector Update: Health Care Stocks Steady Pre-Bell Friday	Apr. 12	MT
Novo Nordisk's Wegovy, Ozempic Have No Added Suicide Risk, EU Says	Apr. 12	MT
European Medicines Agency Finds No Increased Suicide Risk Linked to Weight-loss Drugs	Apr. 12	MT
Novo Nordisk's Wegovy, Ozempic Have No Added Suicide Risk, EU Says	Apr. 12	MT
European Medicines Agency Finds No Increased Suicide Risk Link to Novo Nordisk's Wegovy, Ozempic	Apr. 12	MT
BMO Capital Starts Novo Nordisk With Outperform Rating, $163 Price Target	Apr. 12	MT
EU regulator finds no link between weight-loss drugs and suicidal thoughts	Apr. 12	RE
Gerresheimer shares down on outlook, but key contracts confirmed	Apr. 11	RE